8-K - Neuphoria Therapeutics Inc. (0001191070) (Filer)
Published . Updated .
8-K - Neuphoria Therapeutics filed an 8-K with the SEC on Oct 23 (a notice of a material company event).
Directly affected
- NEUP Neuphoria Therapeutics
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| NEUP | -5.30% | -5.44% | base | +1.43% | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-23 AccNo: 0001213900-26-111863 Size: 216 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.03: Material Modifications to Rights of Security Holders Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Neuphoria Therapeutics (NEUP) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | -0.70% | final price |
| GLD | three days earlier | +2.33% | final price |
| GLD | five days earlier | +3.51% | final price |
| Neuphoria Therapeutics (NEUP) | that day | +1.43% | final price |
| Neuphoria Therapeutics (NEUP) | three days earlier | -5.44% | final price |
| Neuphoria Therapeutics (NEUP) | five days earlier | -5.30% | final price |
| QQQ | that day | -0.02% | final price |
| QQQ | three days earlier | +1.80% | final price |
| QQQ | five days earlier | +0.75% | final price |
| SPY | that day | -0.48% | final price |
| SPY | three days earlier | +0.66% | final price |
| SPY | five days earlier | -0.09% | final price |
| TLT | that day | -0.53% | final price |
| TLT | three days earlier | -1.97% | final price |
| TLT | five days earlier | -2.07% | final price |
Who gains and who loses around Neuphoria Therapeutics (NEUP)
Companies carried with this story
- NEUP Neuphoria Therapeutics
In “8-K - Neuphoria Therapeutics Inc. (0001191070) (Filer),” Neuphoria Therapeutics (NEUP) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> NEUP
How “8-K - Neuphoria Therapeutics Inc. (0001191070) (Filer)” reaches Neuphoria Therapeutics (NEUP)
The 23 Oct 2026 story “8-K - Neuphoria Therapeutics Inc. (0001191070) (Filer)” names Neuphoria Therapeutics (NEUP) because of this story.
For Neuphoria Therapeutics (NEUP), the reason on file says SEC 8-K filing -> direct issuer disclosure -> NEUP
The price range for Neuphoria Therapeutics (NEUP), and the dates in the story
NEUP traded between 3.40 and 3.55 across 2 sessions. The latest close on file is 3.55.
What the saved facts support for Neuphoria Therapeutics (NEUP)
26 out of 100
“8-K - Neuphoria Therapeutics Inc. (0001191070) (Filer)” scores 26 out of 100. The score uses 1 sources, a +1.91% difference versus the S&P 500 (SPY), and 1 linked companies.